49. Brunt, E.M. Nonalcoholic steatohepatitis: a proposal for grading and staging the
histological lesions // Amer. J. Gastroenterol. -1999. - Vol. 94. - P. 2467-247.
50. Bull, F. Advice on exercise from a family physician can help sedentary patients
to become active / F. Bull, K. Jamorozik // Am J Prev Med. - 1998. - Vol. 15. -
P.85-94.
51. Caldwell, S.H. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic
steatohepatitis / S.H. Caldwel // Amer. J. Gastroenterol. - 2001. - Vol. 96. - P.
519-525.
52. Caldwell S.H. Cryptogenic cirrhosis: clinical characterization and risk factors for
underlying disease / S.H. Caldwell // Hepatology. - 1999. -Vol. 29. - P. 664-
669.
53. Campos, H. LDL particle size and coronary artery disease. / H Campos //
Arterioscler Thromb. - 1992.-V o l. 12. - P. 187-195.
54. Carlson, L. Risk factors of myocardial infarction in the Stockholm Prospective
Study. / L.Carlson, L.Bottiger // Acta Med Scand. - 1979. - Vol. 206. - P.351-
358.
55. Castelli, W.P. Incidence of coronary heart disease and lipoprotiein cholesterol
levels: the Framingham Study. / W.P. Castelli // JAMA. - 1986. - Vol. 256. -
P.2838-2853.
56. Clark. J.M. The prevalence and etiology of elevated aminotransferase levels in
the United States / J.M. Clark // Amer J Gastroenterol. - 2003. - Vol. 98(5). -
P.955-956.
57. Clarke, R. Dietary lipids and blood cholesterol: quantitative meta-analysis of
metabolic ward studies. / R. Clarke, C. Frost, R. Collins, et al. // BMJ. - 1997. -
Vol. 314. - P . l 12-117
58. Clinical guidelines on the identification, evaluation, and treatment of overweight
and obesity in adults-the evidence report. National Institutes of Health. // Obes
Res. - 1998. - Vol. 2 (suppl.6). - S51-S209.
89
